-
公开(公告)号:US20220378904A1
公开(公告)日:2022-12-01
申请号:US17737581
申请日:2022-05-05
Applicant: ModernaTX, Inc.
Inventor: Lori Panther , Christine Shaw , Igor Smolenov , Michael Watson , Tal Zaks
Abstract: Provided herein are vaccine composition comprising a chemically-modified messenger ribonucleic acid (mRNA) encoding a hMPV fusion (F) glycoprotein and a chemically-modified mRNA encoding a hPIV3 F glycoprotein formulated in a cationic lipid nanoparticle formulation, and related method for inducing an antigen-specific immune response.
-
公开(公告)号:US11364292B2
公开(公告)日:2022-06-21
申请号:US16898268
申请日:2020-06-10
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K48/00 , A61K9/14 , A61K9/00 , C07K16/28 , C07K14/005 , C07K16/10 , C07K14/18 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , C12N7/00 , A61P31/12 , A61P31/14 , A61K9/51 , A61K39/00
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
公开(公告)号:US20200368344A1
公开(公告)日:2020-11-26
申请号:US16898268
申请日:2020-06-10
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K9/00 , C07K16/28 , C07K14/005 , C07K16/10 , A61K9/14 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , C12N7/00 , A61P31/12 , A61P31/14 , A61K9/51
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
公开(公告)号:US20200289638A1
公开(公告)日:2020-09-17
申请号:US16850519
申请日:2020-04-16
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks
IPC: A61K39/12 , A61K9/00 , A61K9/127 , A61K9/51 , A61K39/015 , A61P11/00 , A61K39/39 , A61K39/42 , A61K48/00
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US20190008946A1
公开(公告)日:2019-01-10
申请号:US16136386
申请日:2018-09-20
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US20180008694A1
公开(公告)日:2018-01-11
申请号:US15674591
申请日:2017-08-11
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks
CPC classification number: A61K39/12 , A61K9/0019 , A61K9/1271 , A61K9/513 , A61K39/015 , A61K39/39 , A61K39/42 , A61K48/00 , A61K2039/51 , A61K2039/5254 , A61K2039/53 , A61K2039/55511 , A61K2039/55555 , A61K2039/575 , C12N2770/24034 , C12N2770/24134 , C12N2770/36134 , Y02A50/383 , Y02A50/386 , Y02A50/392
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US20230020362A1
公开(公告)日:2023-01-19
申请号:US17737532
申请日:2022-05-05
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K9/14 , A61K9/51 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , A61K48/00 , A61P31/12 , A61P31/14 , C07K14/005 , C07K14/18 , C07K16/10 , C07K16/28 , C12N7/00 , A61K9/00
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
公开(公告)号:US20220257746A1
公开(公告)日:2022-08-18
申请号:US17590479
申请日:2022-02-01
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks
IPC: A61K39/12 , A61K9/00 , A61K9/127 , A61K9/51 , A61K39/015 , A61P11/00 , A61K39/39 , A61K39/42 , A61K48/00
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US20220152178A1
公开(公告)日:2022-05-19
申请号:US17554182
申请日:2021-12-17
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Nicholas Valiante , Tal Zaks
Abstract: The invention relates to concatemeric peptide epitope RNAs, as well as methods and compositions thereof. mRNA vaccines are also provided according to the invention, including cancer vaccines.
-
公开(公告)号:US10449244B2
公开(公告)日:2019-10-22
申请号:US16009811
申请日:2018-06-15
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu
IPC: A61K39/12 , A61P31/12 , A61P31/14 , A61K9/14 , A61K9/51 , C07K14/005 , C07K16/10 , C12N7/00 , A61K9/00 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , C07K16/28 , A61K39/00
Abstract: Aspects of the disclosure describe compositions that comprise RNA polynucleotides having an open reading frame encoding one or more Zika virus antigens. Methods for preparing and using the compositions are also described.
-
-
-
-
-
-
-
-
-